Advertisement

Topics

Sandoz And AbbVie Biosimilar Humira Settlement: What Does It Mean?

10:41 EDT 12 Oct 2018 | SCRIP

Sandoz has become the latest firm to sign a settlement agreement over biosimilar Humira with AbbVie, heralding imminent launch in...

      

Related Stories

 

Original Article: Sandoz And AbbVie Biosimilar Humira Settlement: What Does It Mean?

NEXT ARTICLE

More From BioPortfolio on "Sandoz And AbbVie Biosimilar Humira Settlement: What Does It Mean?"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biosimilars
Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...